Your browser doesn't support javascript.
Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19).
Pallotto, Carlo; Blanc, Pierluigi; Esperti, Sara; Suardi, Lorenzo Roberto; Gabbuti, Andrea; Vichi, Francesca; Mecocci, Lorenzo; Esposti, Anna Degli; Pierotti, Piera; Attala, Letizia; Salomoni, Elena; Baragli, Filippo; Francisci, Daniela; Pietro, Massimo Antonio Di.
  • Pallotto C; Infectious Diseases Unit 1, Santa Maria Annunziata Hospital, Azienda USL Toscana Centro, via Antella, 56, Bagno a Ripoli, Florence, Italy; Infectious Diseases Clinic, Santa Maria della Misericordia University Hospital, University of Perugia, Piazzale Gambuli, 1, Perugia, Italy. Electronic address: p
  • Blanc P; Infectious Diseases Unit 1, Santa Maria Annunziata Hospital, Azienda USL Toscana Centro, via Antella, 56, Bagno a Ripoli, Florence, Italy; Infectious Diseases Unit 2, San Jacopo Hospital, Azienda USL Toscana Centro, via Ciliegiole, 97, Pistoia, Italy.
  • Esperti S; Infectious Diseases Unit 1, Santa Maria Annunziata Hospital, Azienda USL Toscana Centro, via Antella, 56, Bagno a Ripoli, Florence, Italy; Department of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.
  • Suardi LR; Infectious Diseases Unit 1, Santa Maria Annunziata Hospital, Azienda USL Toscana Centro, via Antella, 56, Bagno a Ripoli, Florence, Italy; Infectious Diseases Unit, Azienda Ospedaliero Universitaria Pisana, Via Paradisa 2, Pisa, Italy.
  • Gabbuti A; Infectious Diseases Unit 1, Santa Maria Annunziata Hospital, Azienda USL Toscana Centro, via Antella, 56, Bagno a Ripoli, Florence, Italy.
  • Vichi F; Infectious Diseases Unit 1, Santa Maria Annunziata Hospital, Azienda USL Toscana Centro, via Antella, 56, Bagno a Ripoli, Florence, Italy.
  • Mecocci L; Infectious Diseases Unit 1, Santa Maria Annunziata Hospital, Azienda USL Toscana Centro, via Antella, 56, Bagno a Ripoli, Florence, Italy.
  • Esposti AD; Infectious Diseases Unit 1, Santa Maria Annunziata Hospital, Azienda USL Toscana Centro, via Antella, 56, Bagno a Ripoli, Florence, Italy.
  • Pierotti P; Infectious Diseases Unit 1, Santa Maria Annunziata Hospital, Azienda USL Toscana Centro, via Antella, 56, Bagno a Ripoli, Florence, Italy.
  • Attala L; Infectious Diseases Unit 1, Santa Maria Annunziata Hospital, Azienda USL Toscana Centro, via Antella, 56, Bagno a Ripoli, Florence, Italy.
  • Salomoni E; Infectious Diseases Unit 1, Santa Maria Annunziata Hospital, Azienda USL Toscana Centro, via Antella, 56, Bagno a Ripoli, Florence, Italy.
  • Baragli F; Infectious Diseases Unit 1, Santa Maria Annunziata Hospital, Azienda USL Toscana Centro, via Antella, 56, Bagno a Ripoli, Florence, Italy.
  • Francisci D; Infectious Diseases Clinic, Santa Maria della Misericordia University Hospital, University of Perugia, Piazzale Gambuli, 1, Perugia, Italy.
  • Pietro MAD; Infectious Diseases Unit 1, Santa Maria Annunziata Hospital, Azienda USL Toscana Centro, via Antella, 56, Bagno a Ripoli, Florence, Italy.
J Infect ; 83(2): 237-279, 2021 08.
Article in English | MEDLINE | ID: covidwho-1246041
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Bradycardia / COVID-19 Drug Treatment Limits: Humans Language: English Journal: J Infect Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Bradycardia / COVID-19 Drug Treatment Limits: Humans Language: English Journal: J Infect Year: 2021 Document Type: Article